Dechra Pharmaceuticals
Launch date
Employees
Market cap
€5.3b
Enterprise valuation
€5.8b (Public information from Jan 2024)
Share price
£38.58268 DPH.L
Company register number 03369634
Northwich England (HQ)
Financials
Estimates*
GBP | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 515m | 608m | 682m | 762m | 837m | 904m | 954m |
% growth | 7 % | 18 % | 12 % | 12 % | 10 % | 8 % | 6 % |
EBITDA | 131m | 162m | 254m | 98.1m | 232m | 248m | 283m |
% EBITDA margin | 25 % | 27 % | 37 % | 13 % | 28 % | 27 % | 30 % |
Profit | 33.9m | 55.5m | 58.2m | (27.9m) | 97.0m | 123m | 187m |
% profit margin | 7 % | 9 % | 9 % | (4 %) | 12 % | 14 % | 20 % |
EV / revenue | 6.2x | 8.1x | 5.8x | 6.1x | 5.6x | 5.0x | 4.7x |
EV / EBITDA | 24.4x | 30.4x | 15.6x | 47.2x | 20.1x | 18.4x | 15.7x |
R&D budget | 28.4m | 32.4m | 36.1m | 60.8m | - | - | - |
R&D % of revenue | 6 % | 5 % | 5 % | 8 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | £4.5b Valuation: £4.5b 6.5x EV/LTM Revenues 17.6x EV/LTM EBITDA | Buyout | |
Total Funding | - |
Recent News about Dechra Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Dechra Pharmaceuticals
EditACQUISITION by Dechra Pharmaceuticals Jul 2022
ACQUISITION by Dechra Pharmaceuticals Mar 2016
ACQUISITION by Dechra Pharmaceuticals Apr 2012
ACQUISITION by Dechra Pharmaceuticals Aug 2015
ACQUISITION by Dechra Pharmaceuticals Oct 2010
ACQUISITION by Dechra Pharmaceuticals Dec 2018
ACQUISITION by Dechra Pharmaceuticals Jan 2018
ACQUISITION by Dechra Pharmaceuticals Sep 2016
ACQUISITION by Dechra Pharmaceuticals Jul 2024